Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease
Open Access
- 28 December 2001
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 80 (1) , 101-110
- https://doi.org/10.1046/j.0022-3042.2001.00676.x
Abstract
Although the cause of Parkinson's disease (PD) is unknown, data suggest roles for environmental factors that may sensitize dopaminergic neurons to age‐related dysfunction and death. Based upon epidemiological data suggesting roles for dietary factors in PD and other age‐related neurodegenerative disorders, we tested the hypothesis that dietary folate can modify vulnerability of dopaminergic neurons to dysfunction and death in a mouse model of PD. We report that dietary folate deficiency sensitizes mice to MPTP‐induced PD‐like pathology and motor dysfunction. Mice on a folate‐deficient diet exhibit elevated levels of plasma homocysteine. When infused directly into either the substantia nigra or striatum, homocysteine exacerbates MPTP‐induced dopamine depletion, neuronal degeneration and motor dysfunction. Homocysteine exacerbates oxidative stress, mitochondrial dysfunction and apoptosis in human dopaminergic cells exposed to the pesticide rotenone or the pro‐oxidant Fe2+. The adverse effects of homocysteine on dopaminergic cells is ameliorated by administration of the antioxidant uric acid and by an inhibitor of poly (ADP‐ribose) polymerase. The ability of folate deficiency and elevated homocysteine levels to sensitize dopaminergic neurons to environmental toxins suggests a mechanism whereby dietary folate may influence risk for PD.Keywords
This publication has 46 references indexed in Scilit:
- The genetics of Parkinson's diseaseCurrent Opinion in Genetics & Development, 2000
- Elevated Plasma Levels of Homocysteine inParkinson’s DiseaseEuropean Neurology, 1998
- Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivoJournal of Neuroscience Research, 1998
- Homocysteine and vascular disease: nature or nurture?Journal of Cardiovascular Risk, 1998
- Effect of L-Dopa and the Catechol-O-Methyltransferase Inhibitor Ro 41–0960 on Sulfur Amino Acid Metabolites in RatsClinical Neuropharmacology, 1997
- Hyperhomocysteinaemia; with reference to its neuroradiological aspectsNeuroradiology, 1995
- Serum Folate and Risk for Ischemic StrokeStroke, 1995
- Sustained Depletion of Cortical and Hippocampal Serotonin and Norepinephrine but Not Striatal Dopamine by 1‐Methyl‐4‐(2′‐Aminophenyl)‐1,2,3,6‐Tetrahydropyridine (2′‐NH2‐MPTP): A Comparative Study with 2′‐CH3‐MPTP and MPTPJournal of Neurochemistry, 1993
- Synaptosomal plasma membrane transport of excitatory sulphur amino acid transmitter candidates: Kinetic characterisation and analysis of carrier specificityJournal of Neuroscience Research, 1992
- Methionine metabolism in mammalsThe Journal of Nutritional Biochemistry, 1990